SMILES,Name,Conditions,NCT_Number,Phases,Unapproval Probability,Approval Probability
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1,_LEUPROLIDE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.14778936593222045,0.8522106340677795
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,_ESTRADIOL,URINARY TRACT INFECTIONS,NCT04301934,Not Applicable,0.020534558381370544,0.9794654416186296
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,_ESTRADIOL,COVID,NCT04359329,Phase 2,0.030800386386635736,0.9691996136133642
CC(=O)[O-],_ACETATE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.3595464666208381,0.640453533379162
CC(=O)[O-],_ACETATE,HERPES ZOSTER,NCT04258930,Not Applicable,0.16974947186845515,0.830250528131545
CC(=O)[O-],_ACETATE,DEPRESSION,NCT02837432,Early Phase 1,0.2736879611241315,0.7263120388758686
CC(=O)[O-],_ACETATE,HIV-1 INFECTION,NCT03536234,Phase 2,0.2776413112590616,0.7223586887409383
CC(=O)[O-],_ACETATE,BURN,NCT01413620,Phase 1,0.2790406884741157,0.7209593115258847
C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,_EXEMESTANE,OVARIAN CANCER,NCT04460807,Phase 3,0.11787239959657465,0.8821276004034251
N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,_LETROZOLE,OVARIAN CANCER,NCT03378297,Early Phase 1,0.1047006630000804,0.8952993369999196
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.06282036414345535,0.9371796358565448
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.0005939688347738312,0.9994060311652262
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,COVID-19,NCT04451174,Phase 3,0.0005939688347738312,0.9994060311652262
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1,_ABIRATERONE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.2221189964283397,0.7778810035716601
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,NEOPLASMS,NCT03693612,Phase 2,0.8403074923135341,0.15969250768646592
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,PROSTATE CANCER,NCT04194554,Phase 1|Phase 2,0.2601486401939833,0.7398513598060166
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,BREAST CANCER,NCT02826512,Phase 2,0.24011889581632245,0.7598811041836774
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,METASTATIC MELANOMA,NCT03925350,Phase 2,0.311524950107289,0.6884750498927111
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,PROSTATIC NEOPLASMS,NCT03834519,Phase 3,0.29834437707054035,0.7016556229294596
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,OVARIAN CANCER,NCT03464201,Phase 2,0.272820593616016,0.7271794063839839
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,BREAST CANCER,NCT02955394,Phase 2,0.23866947782514156,0.7613305221748584
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,OVARIAN CANCER,NCT03814447,Early Phase 1,0.24047468813921674,0.7595253118607833
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,NEOPLASMS,NCT03967223,Phase 2,0.2200141029751303,0.7799858970248695
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.09564542114616602,0.904354578853834
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,PROSTATE CANCER,NCT03089203,Phase 1,0.1824137558715827,0.8175862441284174
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,GRAFT VS HOST DISEASE,NCT03357159,Phase 2,0.16346133403742066,0.8365386659625794
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,METASTATIC MELANOMA,NCT03475134,Phase 1,0.16346133403742066,0.8365386659625794
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,SICKLE CELL DISEASE,NCT03121001,Phase 2,0.2673435271812501,0.7326564728187499
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,HEMATOLOGICAL MALIGNANCY,NCT03344705,Phase 1,0.22495612197858045,0.7750438780214195
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,HEPATOCELLULAR CARCINOMA,NCT04011033,Phase 2|Phase 3,0.09624911777923968,0.9037508822207602
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,CROHN'S DISEASE,NCT00692939,Phase 1|Phase 2,0.2673435271812501,0.7326564728187499
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,MULTIPLE SCLEROSIS,NCT03477500,Phase 3,0.11337000588461305,0.8866299941153868
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,_METHOTREXATE,BREAST CANCER,NCT02897700,Phase 1,0.035841062678396145,0.9641589373216038
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,_METHOTREXATE,SICKLE CELL DISEASE,NCT02766465,Phase 2,0.3305713300637316,0.6694286699362684
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,_TACROLIMUS,SICKLE CELL DISEASE,NCT02766465,Phase 2,0.10041197055191578,0.8995880294480841
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,_TACROLIMUS,HEMATOLOGICAL MALIGNANCY,NCT01349101,Phase 2,0.03245332261754622,0.9675466773824536
CS(=O)(=O)OCCCCOS(C)(=O)=O,_BUSULFAN,SICKLE CELL DISEASE,NCT02766465,Phase 2,0.9037783966350262,0.0962216033649737
CS(=O)(=O)OCCCCOS(C)(=O)=O,_BUSULFAN,HEMATOLOGICAL MALIGNANCY,NCT01349101,Phase 2,0.6589228754118076,0.3410771245881923
CS(=O)(=O)OCCCCOS(C)(=O)=O,_BUSULFAN,HIV INFECTIONS|AIDS,NCT03517631,Phase 1,0.4530466543229146,0.5469533456770854
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,OVARIAN CANCER,NCT03814447,Early Phase 1,0.6592368144481539,0.3407631855518459
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,NEOPLASMS,NCT03967223,Phase 2,0.7830361795724192,0.21696382042758067
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,GRAFT VS HOST DISEASE,NCT03263767,Phase 2,0.8355228471360746,0.1644771528639254
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,METASTATIC MELANOMA,NCT03475134,Phase 1,0.8806496570768871,0.11935034292311272
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,SICKLE CELL DISEASE,NCT03121001,Phase 2,0.9935220343826192,0.006477965617380636
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,HEMATOLOGICAL MALIGNANCY,NCT03344705,Phase 1,0.6895568512450185,0.31044314875498136
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,HEPATOCELLULAR CARCINOMA,NCT02905188,Phase 1,0.9982114005422592,0.001788599457740605
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,HEPATOCELLULAR CARCINOMA,NCT04411706,Phase 2,0.4701057951828708,0.5298942048171291
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_EVEROLIMUS,END STAGE RENAL DISEASE,NCT03413722,,0.136420777998238,0.8635792220017621
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,METASTATIC BREAST CANCER,NCT03901339,Phase 3,0.4049917515771423,0.5950082484228577
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,NEOPLASMS,NCT03693612,Phase 2,0.43620492658523147,0.5637950734147686
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,PROSTATIC NEOPLASMS,NCT03834519,Phase 3,0.4197292273099708,0.5802707726900294
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,OVARIAN CANCER,NCT03378297,Early Phase 1,0.3902706362291879,0.6097293637708122
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,PROSTATE CANCER,NCT03810105,Phase 2,0.5176094210860239,0.4823905789139761
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.008340878479433038,0.9916591215205668
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,COVID-19,NCT04329650,Phase 2,0.008340878479433038,0.9916591215205668
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,PNEUMONIA,NCT03852537,Phase 2,0.02106808252258793,0.9789319174774119
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,COVID-19 PNEUMONIA,NCT04438980,Phase 3,0.008340878479433038,0.9916591215205668
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,CONTRACEPTION,NCT02799641,Not Applicable,0.03973413263505924,0.9602658673649408
CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,_DAPTOMYCIN,STAPHYLOCOCCUS AUREUS BACTEREMIA,NCT03138733,Phase 3,0.02929357298532173,0.970706427014678
CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,_DAPTOMYCIN,ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION,NCT04298463,,0.11673969039856015,0.8832603096014395
Nc1nc(/C(=N/O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(/C=C4\CCN([C@@H]5CCNC5)C4=O)CS[C@H]23)ns1,_CEFTOBIPROLE,STAPHYLOCOCCUS AUREUS BACTEREMIA,NCT03138733,Phase 3,0.7975685545198188,0.20243144548018133
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,_VANCOMYCIN,ULCERATIVE COLITIS,NCT03759041,Phase 2,0.003153094946661552,0.9968469050533384
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,_VANCOMYCIN,ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION,NCT04298463,,0.1001820655849877,0.8998179344150123
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,_VANCOMYCIN,PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS,NCT03685747,Phase 1,0.009596806718222032,0.9904031932817778
CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O,_TEICOPLANIN,ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION,NCT04298463,,0.2642250344556996,0.7357749655443007
CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O,_TEICOPLANIN,BACTERIAL INFECTIONS,NCT03933748,,0.19258752096521733,0.8074124790347829
CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O,_TEICOPLANIN,CYSTIC FIBROSIS,NCT04176328,Phase 1,0.20692843503343186,0.7930715649665683
CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O,_PIPERACILLIN,APPENDICITIS,NCT02991937,Not Applicable,0.008674863387978142,0.9913251366120218
NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,_AMIKACIN,"SHOCK, SEPTIC",NCT04178148,Not Applicable,0.12791183197393885,0.8720881680260609
NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,_AMIKACIN,TUBERCULOSIS,NCT04249531,Phase 1,0.0742483967272763,0.9257516032727237
NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,_AMIKACIN,PNEUMONIA VENTILATOR ASSOCIATED,NCT03149640,Phase 3,0.12791183197393885,0.8720881680260609
CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,_LINEZOLID,TUBERCULOSIS,NCT04545788,Not Applicable,0.020263669466686028,0.979736330533314
CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,_LINEZOLID,TUBERCULOUS MENINGITIS,NCT03898635,,0.17003360084479793,0.8299663991552022
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,_MEROPENEM,"TUBERCULOSIS, PULMONARY",NCT03174184,Phase 2,0.002433347746239421,0.9975666522537604
CNC(C)C1CCC(N)C(OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O)O1,_GENTAMICIN,GONORRHEA,NCT03294395,Phase 3,0.01683498069428561,0.9831650193057144
CNC(C)C1CCC(N)C(OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O)O1,_GENTAMICIN,ABDOMINAL ABSCESS,NCT03476941,Phase 2,0.01743061233973525,0.9825693876602648
Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1,_GANCICLOVIR,TRANSPLANTATION INFECTION|CYTOMEGALOVIRUS INFECTIONS,NCT03699254,Phase 3,0.010748396780627138,0.9892516032193728
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,_CYCLOSPORINE,COVID-19,NCT04412785,Phase 1,0.16366331733058895,0.8363366826694107
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,_MYCOPHENOLATE_MOFETIL,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.0278850978683132,0.9721149021316868
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,_MYCOPHENOLATE_MOFETIL,SICKLE CELL DISEASE,NCT03121001,Phase 2,0.1672501131016545,0.8327498868983453
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,_MYCOPHENOLATE_MOFETIL,HEMATOLOGICAL MALIGNANCY,NCT01349101,Phase 2,0.11560185792950685,0.8843981420704929
S=P(N1CC1)(N1CC1)N1CC1,_THIOTEPA,BREAST CANCER,NCT01646034,Phase 3,0.1713675985441125,0.8286324014558872
S=P(N1CC1)(N1CC1)N1CC1,_THIOTEPA,SICKLE CELL DISEASE,NCT04362293,Phase 2,0.29645642963450863,0.7035435703654914
S=P(N1CC1)(N1CC1)N1CC1,_THIOTEPA,CROHN'S DISEASE,NCT00692939,Phase 1|Phase 2,0.3542754991523929,0.6457245008476071
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,COVID-19,NCT04341675,Phase 2,0.020897192769846272,0.9791028072301536
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,SICKLE CELL DISEASE,NCT03121001,Phase 2,0.07578809313677164,0.9242119068632284
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,ISCHEMIC HEART DISEASE,NCT03600961,,0.10924655890692367,0.8907534410930761
N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,_MELPHALAN,METASTATIC MELANOMA,NCT01920516,,0.6284672504963039,0.3715327495036957
N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,_MELPHALAN,SICKLE CELL DISEASE,NCT02766465,Phase 2,0.9075309094143136,0.09246909058568636
N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,_MELPHALAN,CROHN'S DISEASE,NCT00692939,Phase 1|Phase 2,0.8686231442157473,0.13137685578425298
N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,_MELPHALAN,NON-CYSTIC FIBROSIS BRONCHIECTASIS,NCT04278040,Phase 2,0.5727020869073735,0.4272979130926264
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,DEPRESSION,NCT02837432,Early Phase 1,0.06978380684841773,0.9302161931515822
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,PROSTATE CANCER,NCT00859781,Phase 2,0.1053680753106436,0.8946319246893562
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,SEPSIS,NCT04160676,Not Applicable,0.014471310980725809,0.9855286890192742
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,"SHOCK, SEPTIC",NCT03592693,Phase 2,0.014471310980725809,0.9855286890192742
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,COMMUNITY ACQUIRED PNEUMONIA,NCT02517489,Phase 3,0.014471310980725809,0.9855286890192742
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,HIV INFECTION,NCT03237689,Early Phase 1,0.13436542950529726,0.8656345704947025
COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,_ETOPOSIDE,COVID-19,NCT04356690,Phase 2,0.6474307386233898,0.35256926137661004
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISOLONE,PROSTATIC NEOPLASMS,NCT04034095,,0.02628419970326833,0.9737158002967315
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISOLONE,ASTHMA IN CHILDREN,NCT03962894,,0.1616199744877061,0.8383800255122941
Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12,_AZATHIOPRINE,SICKLE CELL DISEASE,NCT04362293,Phase 2,0.20581709502274856,0.7941829049772515
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,PROSTATE CANCER,NCT03513211,Phase 1|Phase 2,0.04178139174221025,0.9582186082577896
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,MULTIPLE SCLEROSIS,NCT03109288,Phase 1|Phase 2,0.13922461927274266,0.8607753807272573
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,TYPE 1 DIABETES,NCT03428945,Phase 2,0.05798938878867437,0.9420106112113256
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,MULTIPLE SCLEROSIS,NCT03824938,Phase 1|Phase 2,0.17910595785821493,0.8208940421417851
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,DIABETIC FOOT,NCT03871049,Not Applicable,0.0015068822023047376,0.9984931177976952
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,GRAFT VS HOST DISEASE,NCT00391170,Phase 2,0.030619874967498455,0.9693801250325016
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,VITILIGO,NCT04030988,Phase 1,0.005837608973233901,0.9941623910267662
OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,_DEXTROSE,HYSTERECTOMY,NCT03719755,Not Applicable,0.27879314120863546,0.7212068587913645
C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O,_SOMATOSTATIN,HEPATOCELLULAR CARCINOMA,NCT02799212,Phase 3,0.22144958454940453,0.7785504154505954
C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,_CABERGOLINE,ENDOMETRIOSIS,NCT03928288,Phase 2,0.1701991795267771,0.8298008204732232
CC(C)NCC(O)COc1cccc2ccccc12,_PROPRANOLOL,PORTAL HYPERTENSION,NCT03094234,Not Applicable,0.04787653077038193,0.952123469229618
CC(C)NCC(O)COc1cccc2ccccc12,_PROPRANOLOL,OBSTRUCTIVE SLEEP APNEA,NCT03049306,Phase 2,0.2182508383628699,0.7817491616371299
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,MULTIPLE SCLEROSIS,NCT04035889,Not Applicable,0.15581209100933438,0.8441879089906656
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,OBSTRUCTIVE SLEEP APNEA,NCT02484300,Not Applicable,0.2255831294790872,0.774416870520913
Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,_FOLIC_ACID,DELIRIUM,NCT04456985,Not Applicable,0.09661473587079293,0.9033852641292072
Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,_FOLIC_ACID,ANEMIA,NCT04404751,Not Applicable,0.10951856592335854,0.8904814340766416
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,_AZITHROMYCIN,LOWER RESPIRATORY TRACT INFECTION,NCT03341273,Not Applicable,0.011566382261292064,0.988433617738708
NC(=O)c1cccnc1,_NICOTINAMIDE,SICKLE CELL DISEASE,NCT04055818,Phase 1,0.5421717080222168,0.4578282919777832
NC(=O)c1cccnc1,_NICOTINAMIDE,PREECLAMPSIA,NCT03419364,Phase 2,0.4919616948160037,0.5080383051839963
NC(=O)c1cccnc1,_NIACINAMIDE,SICKLE CELL DISEASE,NCT04055818,Phase 1,0.5421717080222168,0.4578282919777832
NC(=O)c1cccnc1,_NIACINAMIDE,PREECLAMPSIA,NCT03419364,Phase 2,0.4919616948160037,0.5080383051839963
c1ccc([C@H]2CN3CCSC3=N2)cc1,_LEVAMISOLE,COVID-19,NCT04331470,Phase 2|Phase 3,0.1073782126226746,0.8926217873773254
NC(=O)CC[C@H](N)C(=O)O,_GLUTAMINE,BURN,NCT00985205,Phase 3,0.22963655002277625,0.7703634499772238
NC(=O)CC[C@H](N)C(=O)O,_L-GLUTAMINE,BURN,NCT00985205,Phase 3,0.22963655002277625,0.7703634499772238
O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,_ASCORBIC_ACID,SEPSIS,NCT04160676,Not Applicable,0.07022448355972773,0.929775516440272
Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1,_THIAMINE,SEPSIS,NCT04160676,Not Applicable,0.08467314107479483,0.9153268589252052
Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1,_THIAMINE,DELIRIUM,NCT04214106,,0.2574140281054149,0.7425859718945851
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,BREAST CANCER,NCT02790580,Phase 2,0.20780781940671572,0.7921921805932844
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,_RUXOLITINIB,COVID-19,NCT04377620,Phase 3,0.3913395886869505,0.6086604113130495
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,_RUXOLITINIB,CORONAVIRUS INFECTION,NCT04348695,Phase 2,0.3843048287586647,0.6156951712413353
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,_RUXOLITINIB,MALARIA,NCT04456634,Phase 1,0.3125762907348232,0.6874237092651769
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,_DOXORUBICIN,METASTATIC BREAST CANCER,NCT04159818,Phase 2,0.2796429232047799,0.7203570767952201
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,_DOXORUBICIN_HYDROCHLORIDE,OVARIAN CANCER,NCT04337632,Phase 3,0.3837607234351241,0.616239276564876
COC(=O)C(c1ccccc1)C1CCCCN1,_METHYLPHENIDATE,ANXIETY,NCT02153944,Not Applicable,0.21558245684533792,0.7844175431546622
O=C([O-])[O-].[Ca+2],_CALCIUM_CARBONATE,LIVER CIRRHOSIS,NCT02642874,Phase 3,0.1120570313439572,0.8879429686560429
O=C([O-])[O-].[Ca+2],_CALCIUM_CARBONATE,OSTEOPOROSIS,NCT04550078,Not Applicable,0.15986717213696042,0.8401328278630396
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03953261,Phase 2,0.23273445875799184,0.7672655412420083
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,PROSTATE CANCER,NCT03769766,Phase 3,0.2353023619878108,0.7646976380121895
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,BREAST CANCER,NCT03980509,Phase 1,0.4711322043472825,0.5288677956527176
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,ULCERATIVE COLITIS,NCT02277223,Phase 3,0.13090306581723296,0.8690969341827671
N[C@@H](CS)C(=O)O,_CYSTEINE,COVID-19,NCT04370288,Phase 1,0.08258960188285358,0.9174103981171464
N[C@@H](CS)C(=O)O,_CYSTEINE,"TUBERCULOSIS, PULMONARY",NCT03702738,Phase 2,0.08258960188285358,0.9174103981171464
Cn1c(=O)c2c(ncn2C)n(C)c1=O,_CAFFEINE,HIV INFECTION,NCT04425902,Phase 1,0.3473806700679956,0.6526193299320044
Cn1c(=O)c2c(ncn2C)n(C)c1=O,_CAFFEINE,CROHN'S DISEASE,NCT03358706,Phase 1,0.1839257817750674,0.8160742182249325
Cn1c(=O)c2c(ncn2C)n(C)c1=O,_CAFFEINE,CATARACT,NCT03534973,Not Applicable,0.10385140005216936,0.8961485999478306
Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2,_VITAMIN_E,BREAST CANCER,NCT04463459,Not Applicable,0.09873085661258818,0.9012691433874116
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C,_CHOLECALCIFEROL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,NCT04011930,Phase 2,0.06943188697106745,0.9305681130289326
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C,_CHOLECALCIFEROL,END STAGE RENAL DISEASE,NCT04145492,Phase 2|Phase 3,0.06068345635788139,0.9393165436421188
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C,_CHOLECALCIFEROL,ATOPIC DERMATITIS,NCT02537509,Phase 2,0.06368104097985798,0.936318959020142
CN(C)C(=N)NC(=N)N,_METFORMIN,OVARIAN CANCER,NCT03378297,Early Phase 1,0.1126546426939884,0.8873453573060115
CN(C)C(=N)NC(=N)N,_METFORMIN,BREAST CANCER,NCT04559308,Phase 2,0.05084819995358677,0.949151800046413
CN(C)C(=N)NC(=N)N,_METFORMIN,HIV/AIDS,NCT04500678,Phase 2|Phase 3,0.13884040479824258,0.8611595952017572
CN(C)C(=N)NC(=N)N,_METFORMIN,HEART FAILURE,NCT03331861,Phase 2,0.14826050201331853,0.8517394979866814
CN(C)C(=N)NC(=N)N,_METFORMIN,PREECLAMPSIA,NCT03717701,Not Applicable,0.10093194333462292,0.8990680566653769
CN(C)C(=N)NC(=N)N,_METFORMIN,RHEUMATOID ARTHRITIS,NCT04068246,Early Phase 1,0.04109314944853626,0.9589068505514636
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,NEOPLASMS,NCT02964013,Phase 1,0.6059006251142829,0.3940993748857171
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,OVARIAN CANCER,NCT03378297,Early Phase 1,0.10399118862258233,0.8960088113774176
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,COVID-19,NCT04333407,Not Applicable,0.06452492296076417,0.9354750770392356
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,SEPSIS,NCT01784159,Phase 2,0.04582449789592902,0.954175502104071
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,MULTIPLE SCLEROSIS,NCT03824938,Phase 1|Phase 2,0.18935014854142407,0.8106498514585759
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,OVARIAN CANCER,NCT03378297,Early Phase 1,0.10399118862258233,0.8960088113774176
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,COVID-19,NCT04333407,Not Applicable,0.06452492296076417,0.9354750770392356
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,SEPSIS,NCT01784159,Phase 2,0.04582449789592902,0.954175502104071
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,MULTIPLE SCLEROSIS,NCT03824938,Phase 1|Phase 2,0.18935014854142407,0.8106498514585759
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,_MORPHINE,CESAREAN SECTION,NCT03427463,Early Phase 1,0.0456930471675344,0.9543069528324656
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,_MORPHINE,NEUROPATHIC PAIN,NCT01914042,Phase 2,0.06519331734922075,0.9348066826507792
NC(N)=O,_UREA,HELICOBACTER PYLORI INFECTION,NCT04233684,Not Applicable,0.1877689624876336,0.8122310375123665
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,_ATORVASTATIN,COVID-19,NCT04333407,Not Applicable,0.04361643412803086,0.9563835658719692
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,_ATORVASTATIN,BREAST CANCER,NCT02958852,Phase 2,0.031823795517532165,0.968176204482468
CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C,_ANGIOTENSIN,RHEUMATOID ARTHRITIS,NCT03770702,Phase 3,0.10035854258434232,0.8996414574156576
NNC(=O)c1ccncc1,_ISONIAZID,TUBERCULOUS MENINGITIS,NCT03787940,Not Applicable,0.009434686900022672,0.9905653130999772
CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,_PRAVASTATIN,HIV INFECTION,NCT04425902,Phase 1,0.171662024673639,0.8283379753263609
CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,_PRAVASTATIN,PREECLAMPSIA,NCT03648970,Phase 2,0.02997872946600664,0.9700212705339932
CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,_PRAVASTATIN,TUBERCULOSIS,NCT03456102,Phase 2,0.10121294457311317,0.8987870554268866
COCCc1ccc(OCC(O)CNC(C)C)cc1,_METOPROLOL,HIV INFECTION,NCT04425902,Phase 1,0.26844610961711224,0.7315538903828878
COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1,_OMEPRAZOLE,COVID-19,NCT04333407,Not Applicable,0.004081389359758235,0.9959186106402416
COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1,_OMEPRAZOLE,HIV INFECTION,NCT04425902,Phase 1,0.06807607825653622,0.9319239217434638
COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1,_OMEPRAZOLE,CROHN'S DISEASE,NCT03358706,Phase 1,0.05515478790656563,0.9448452120934344
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,HIV INFECTION,NCT04425902,Phase 1,0.05617476375759728,0.9438252362424028
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,RHEUMATOID ARTHRITIS,NCT03770923,Phase 3,0.0015068822023047376,0.9984931177976952
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,PAIN,NCT02793375,Phase 3,0.020852638876779173,0.9791473611232208
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,BREAST CANCER,NCT04172220,Not Applicable,0.032721339883637256,0.9672786601163628
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,HIV INFECTION,NCT04425902,Phase 1,0.2349390436638344,0.7650609563361658
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,CROHN'S DISEASE,NCT03358706,Phase 1,0.16278306657482627,0.8372169334251736
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,"HEPATITIS B, CHRONIC",NCT02952924,Phase 1,0.1472165527787514,0.8527834472212484
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,FATIGUE,NCT04141696,Phase 1|Phase 2,0.1059795425756706,0.8940204574243295
CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,_ROSUVASTATIN,OVARIAN CANCER,NCT03532139,Phase 2,0.1823749318279243,0.8176250681720755
CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,_SIMVASTATIN,CORONAVIRUS INFECTION,NCT04348695,Phase 2,0.12160677273966612,0.8783932272603339
CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,_SIMVASTATIN,CIRRHOSIS,NCT02968810,Phase 2,0.119220922814797,0.8807790771852031
O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1,_EZETIMIBE,CHRONIC HEPATITIS C,NCT02971033,Phase 2,0.24927802991697426,0.7507219700830257
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,_RAMIPRIL,COVID-19,NCT04366050,Phase 2,0.17765712571085515,0.822342874289145
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,_RAMIPRIL,MYOCARDIAL INFARCTION,NCT03715998,Phase 2,0.14878412675876238,0.8512158732412377
NCC(CC(=O)O)c1ccc(Cl)cc1,_BACLOFEN,CIRRHOSIS,NCT04509336,Not Applicable,0.06076194380380801,0.939238056196192
Cc1ccccc1C(OCCN(C)C)c1ccccc1,_ORPHENADRINE,CIRRHOSIS,NCT04509336,Not Applicable,0.14619840410863588,0.8538015958913641
COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,_ESMOLOL,SEPTIC SHOCK,NCT03208257,Phase 2,0.3827893999369514,0.6172106000630487
COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,_ESMOLOL,DIABETIC FOOT ULCER,NCT03998436,Phase 3,0.08246279825931492,0.9175372017406852
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,BREAST CANCER,NCT03109990,Not Applicable,0.017557324234503284,0.9824426757654968
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,INFECTIVE ENDOCARDITIS,NCT02698930,Not Applicable,0.014861024913793732,0.9851389750862064
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,KIDNEY TRANSPLANTATION,NCT03327389,Not Applicable,0.014861024913793732,0.9851389750862064
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,_BORTEZOMIB,HEMATOLOGICAL MALIGNANCY,NCT03850366,Phase 2,0.9573709733201184,0.04262902667988178
Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F,_CLOFARABINE,GRAFT VS HOST DISEASE,NCT03263767,Phase 2,0.5680515509668433,0.4319484490331566
CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)nc(N)[nH]c21,_VALGANCICLOVIR,TRANSPLANTATION INFECTION|CYTOMEGALOVIRUS INFECTIONS,NCT03699254,Phase 3,0.040489460891900114,0.9595105391081
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,_SORAFENIB,"CARCINOMA, HEPATOCELLULAR",NCT02794337,Phase 2|Phase 3,0.17130051625459555,0.8286994837454046
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,_IMATINIB,COVID-19 PNEUMONIA,NCT04346147,Phase 2,0.12107658489717125,0.8789234151028286
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,_IMATINIB,PLASMODIUM FALCIPARUM MALARIA (DRUG RESISTANT),NCT03697668,Phase 2,0.23425678312678674,0.765743216873213
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,COVID-19,NCT04335123,Phase 1,0.198001910424693,0.8019980895753072
O=C(CCCCCCC(=O)Nc1ccccc1)NO,_VORINOSTAT,CROHN'S DISEASE,NCT03167437,Phase 1|Phase 2,0.8812802517204785,0.11871974827952175
O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1,_COBIMETINIB,METASTATIC MELANOMA,NCT04109456,Phase 1,0.491076754589316,0.508923245410684
COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,_LENVATINIB,BREAST CANCER,NCT03168074,Phase 2,0.3961663899502682,0.6038336100497319
CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1,_VENETOCLAX,BREAST CANCER,NCT04298918,Phase 1|Phase 2,0.4140203615606765,0.5859796384393237
CN(C)C(=N)N=C(N)N.Cl,_METFORMIN_HYDROCHLORIDE,BREAST CANCER,NCT04170465,Phase 2,0.16160617402616467,0.8383938259738354
CN(C)C(=N)N=C(N)N.Cl,_METFORMIN_HYDROCHLORIDE,HEART FAILURE,NCT03331861,Phase 2,0.23816701989878755,0.7618329801012124
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,_IBRUTINIB,PROSTATE CANCER,NCT02643667,Phase 1|Phase 2,0.5168216369065641,0.4831783630934358
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,_IBRUTINIB,GRAFT VS HOST DISEASE,NCT04235036,Phase 2,0.6482630119254896,0.3517369880745101
C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,_DOXYCYCLINE,ULCERATIVE COLITIS,NCT02606032,Phase 2,0.0033388968473744268,0.9966611031526256
C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,_DOXYCYCLINE,INFERTILITY,NCT03824340,Not Applicable,0.005819118930028185,0.994180881069972
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O,_EXENATIDE,SMOKING CESSATION,NCT02975297,Phase 1|Phase 2,0.12516556189954542,0.8748344381004546
O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,_DICLOFENAC,BREAST CANCER,NCT04511832,Not Applicable,0.14674488883074374,0.8532551111692563
OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,_FLUCONAZOLE,CRYPTOCOCCAL MENINGITIS,NCT03945448,Phase 2|Phase 3,0.02463089003255776,0.9753691099674424
CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,_POSACONAZOLE,INVASIVE ASPERGILLOSIS,NCT04218851,Phase 2,0.1314726342257315,0.8685273657742684
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,_TRIMETHOPRIM,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.3622458552049948,0.6377541447950053
CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O,_CASPOFUNGIN,FUNGAL INFECTION,NCT03857399,Phase 2,0.07409763721184054,0.9259023627881594
C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,_VORICONAZOLE,INVASIVE PULMONARY ASPERGILLOSIS,NCT03672292,Phase 2,0.14091175618011278,0.8590882438198874
O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,_CIPROFLOXACIN,PNEUMONIA,NCT03177720,Phase 1,0.0017516279069767445,0.9982483720930232
CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,_CLOBETASOL_PROPIONATE,CATARACT,NCT04249076,Phase 3,0.1155293720813218,0.8844706279186779
CCC[C@@H]1C[C@@H](C(=O)NC(C(C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1,_CLINDAMYCIN,"INFECTIONS, BACTERIAL",NCT04067531,Phase 3,0.07560227472620074,0.9243977252737992
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,_AMOXICILLIN,INFECTION,NCT03844776,Not Applicable,0.00381947261663286,0.9961805273833672
COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,_DEXTROMETHORPHAN,CROHN'S DISEASE,NCT03358706,Phase 1,0.13502981228319386,0.8649701877168061
CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,_WARFARIN,CROHN'S DISEASE,NCT03358706,Phase 1,0.2548643212803429,0.7451356787196572
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,PREECLAMPSIA,NCT03724838,Not Applicable,0.084023774454178,0.915976225545822
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,CYSTIC FIBROSIS,NCT04039087,Phase 2|Phase 3,0.1080522035471777,0.8919477964528224
COc1ccc2[nH]c([S@@](=O)Cc3ncc(C)c(OC)c3C)nc2c1,_ESOMEPRAZOLE,PREECLAMPSIA,NCT03717701,Not Applicable,0.026751378057775624,0.9732486219422244
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_CHLOROQUINE,COVID,NCT04349371,Phase 2,0.021082104828704783,0.9789178951712952
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=P(O)(O)O,_CHLOROQUINE_PHOSPHATE,COVID-19 PNEUMONIA,NCT04428268,Phase 2,0.018831178930923453,0.9811688210690764
COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC,_SULFADOXINE,MALARIA IN PREGNANCY,NCT03998839,,0.1739690460160735,0.8260309539839267
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CSSC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C,_PROCALCITONIN,PNEUMONIA,NCT03711227,,0.334275454341525,0.6657245456584753
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CSSC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C,_PROCALCITONIN,LOWER RESPIRATORY TRACT INFECTION,NCT03341273,Not Applicable,0.22163407974641036,0.7783659202535899
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CSSC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C,_PROCALCITONIN,"INFLUENZA, HUMAN",NCT02899065,Not Applicable,0.1801806387724045,0.8198193612275955
CC[C@@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,_IVERMECTIN,COVID-19,NCT04429711,Not Applicable,0.005414929844979223,0.9945850701550208
CC[C@@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,_IVERMECTIN,CORONAVIRUS INFECTION,NCT04431466,Phase 2,0.005414929844979223,0.9945850701550208
CC[C@@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,_IVERMECTIN,MALARIA,NCT03967054,Phase 3,0.005414929844979223,0.9945850701550208
CC[C@@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,_IVERMECTIN,CORONAVIRUS INFECTIONS,NCT04384458,Not Applicable,0.005414929844979223,0.9945850701550208
Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,_LOPINAVIR,COVID-19 PNEUMONIA,NCT04346147,Phase 2,0.0032448733413751514,0.9967551266586248
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O,_RIFABUTIN,PULMONARY TUBERCULOSIS,NCT02256696,Phase 2,0.05312327338755317,0.9468767266124468
COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,_MOXIFLOXACIN,DIABETES,NCT01984827,Phase 1,0.03876590974093422,0.9612340902590656
CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,_TIGECYCLINE,SPONTANEOUS BACTERIAL PERITONITIS,NCT04208763,Not Applicable,0.0192014148224592,0.9807985851775408
CC(C)N=c1cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1,_CLOFAZIMINE,COVID-19,NCT04465695,Phase 2,0.017318342050428804,0.9826816579495712
CC(C)N=c1cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1,_CLOFAZIMINE,MYCOBACTERIUM AVIUM COMPLEX,NCT02968212,Phase 2,0.20221709059462367,0.7977829094053763
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCC/N=C/N)C[C@H]12,_IMIPENEM,PNEUMONIA,NCT03177720,Phase 1,0.0015106634154490814,0.9984893365845509
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCC/N=C/N)C[C@H]12,_IMIPENEM,SPONTANEOUS BACTERIAL PERITONITIS,NCT04208763,Not Applicable,0.0015106634154490814,0.9984893365845509
COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12,_BEDAQUILINE,TUBERCULOSIS,NCT04545788,Not Applicable,0.19125694011818128,0.8087430598818185
COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12,_BEDAQUILINE,TUBERCULOSIS|HIV INFECTIONS,NCT02906007,Phase 1|Phase 2,0.2898855551331838,0.710114444866816
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,_CO-TRIMOXAZOLE,SPONTANEOUS BACTERIAL PERITONITIS,NCT04395365,Phase 3,0.10092047817069748,0.8990795218293024
O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,_ROFLUMILAST,ASTHMA,NCT04108377,Phase 1,0.10045416249946257,0.8995458375005374
[Cl-].[Na+],_SODIUM_CHLORIDE,COVID-19,NCT04364763,Phase 2,0.36824614440266906,0.6317538555973311
[Cl-].[Na+],_SODIUM_CHLORIDE,CROHN'S DISEASE,NCT03681067,Phase 1|Phase 2,0.2285990254536002,0.7714009745463997
[Cl-].[Na+],_SODIUM_CHLORIDE,CHRONIC HEPATITIS B,NCT04465890,Phase 2,0.2423956043710175,0.7576043956289825
[Cl-].[Na+],_SODIUM_CHLORIDE,ACUTE PANCREATITIS,NCT03684278,Phase 2,0.21111809929510905,0.7888819007048908
CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1,_CAMOSTAT,COVID-19,NCT04353284,Phase 2,0.17176678094275272,0.8282332190572472
CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1,_CAMOSTAT,CORONA VIRUS INFECTION,NCT04321096,Phase 1|Phase 2,0.11419456401825402,0.8858054359817459
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_BUDESONIDE,COVID-19,NCT04331470,Phase 2|Phase 3,0.01166045276097238,0.9883395472390276
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_BUDESONIDE,INTUBATION COMPLICATION,NCT03250975,Phase 1|Phase 2,0.015552833491663344,0.9844471665083364
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_BUDESONIDE,CHRONIC SINUSITIS,NCT04163978,Phase 2,0.014824892370573547,0.9851751076294264
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_BUDESONIDE,SINUSITIS,NCT03584178,Not Applicable,0.015076635634702426,0.9849233643652976
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,ULCERATIVE COLITIS,NCT02606032,Phase 2,0.0015062069326561506,0.998493793067344
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,INFECTION,NCT03844776,Not Applicable,0.006356299658804925,0.993643700341195
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,PERIODONTITIS,NCT03733379,Phase 3,0.0015062069326561506,0.998493793067344
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,BACTERIAL VAGINOSES,NCT03954990,Phase 1,0.029867825974662542,0.9701321740253374
CN(C)C(=O)Oc1ccc[n+](C)c1,_PYRIDOSTIGMINE,COVID-19|SARS-COV-2,NCT04343963,Phase 2|Phase 3,0.16956804040266776,0.8304319595973321
CN(C)C(=O)Oc1ccc[n+](C)c1.[Br-],_PYRIDOSTIGMINE_BROMIDE,COVID-19|SARS-COV-2,NCT04343963,Phase 2|Phase 3,0.4725139965347281,0.5274860034652721
O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,_RIVAROXABAN,COVID-19,NCT04333407,Not Applicable,0.14693965171038212,0.8530603482896179
O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,_RIVAROXABAN,LIVER CIRRHOSIS,NCT03005444,Not Applicable,0.12613450095835255,0.8738654990416472
CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,_FLUOXETINE,TYPE 1 DIABETES,NCT03228732,Early Phase 1,0.14795894587494562,0.8520410541250546
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)O)c4)C3)[C@H](C)[C@H]12,_ERTAPENEM,URINARY TRACT INFECTIONS,NCT03218800,Phase 3,0.0018003633234534848,0.9981996366765464
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)O)c4)C3)[C@H](C)[C@H]12,_ERTAPENEM,GONORRHEA,NCT03294395,Phase 3,0.0018003633234534848,0.9981996366765464
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1,_CEFOTAXIME,SPONTANEOUS BACTERIAL PERITONITIS,NCT04168099,Phase 3,0.00881947261663286,0.9911805273833671
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,_CEFUROXIME,ENDOPHTHALMITIS POSTOPERATIVE,NCT04212078,Phase 1|Phase 2,0.12628991287447858,0.8737100871255216
CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,_MINOCYCLINE,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.09789805459610992,0.9021019454038895
C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O,_CANNABIDIOL,ANXIETY,NCT02548559,Phase 2,0.4103030595151536,0.5896969404848464
CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,_NITAZOXANIDE,COVID-19,NCT04463264,Phase 2|Phase 3,0.1258614146702701,0.8741385853297297
CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,_NITAZOXANIDE,CHRONIC HEPATITIS B,NCT03905655,Phase 2,0.13791209416028946,0.8620879058397104
COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,_COLCHICINE,COVID,NCT04367168,Phase 2,0.06753979045521542,0.9324602095447844
COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,_COLCHICINE,COVID-19,NCT04360980,Phase 2,0.06753979045521542,0.9324602095447844
COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,_COLCHICINE,CORONAVIRUS INFECTION,NCT04363437,Phase 2,0.07702853630091913,0.9229714636990808
COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,_COLCHICINE,CORONA VIRUS INFECTION,NCT04322682,Phase 3,0.2742634388555677,0.7257365611444322
CC(C)Cn1cnc2c(N)nc3ccccc3c21,_IMIQUIMOD,METASTATIC BREAST CANCER,NCT03982004,Phase 1,0.33104632573868736,0.6689536742613127
CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12,_TERBINAFINE,ULCERATIVE COLITIS,NCT02606032,Phase 2,0.22866775502922465,0.7713322449707751
CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1,_CEPHALEXIN,CYSTIC FIBROSIS,NCT04553419,Phase 3,0.0194079658597644,0.9805920341402355
CC(=O)[O-].CC(=O)[O-].[Ca+2],_CALCIUM_ACETATE,HERPES ZOSTER,NCT04258930,Not Applicable,0.10124942330187832,0.8987505766981216
N[C@@H]1CONC1=O,_CYCLOSERINE,TUBERCULOSIS,NCT04545788,Not Applicable,0.2443179586398713,0.7556820413601288
c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,_PLERIXAFOR,SICKLE CELL DISEASE,NCT04362293,Phase 2,0.4002794649903648,0.5997205350096353
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,_CARVEDILOL,PROSTATE CANCER,NCT02944201,Phase 2,0.2164372532131137,0.7835627467868863
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,_CARVEDILOL,BREAST CANCER,NCT03879629,Phase 2,0.2010127038419936,0.7989872961580065
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,_CARVEDILOL,CIRRHOSIS,NCT01212250,Not Applicable,0.04360877536458102,0.9563912246354188
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl,_MOMETASONE,SICKLE CELL DISEASE,NCT03758950,Phase 2,0.04951055702572865,0.9504894429742712
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,_FENTANYL,HEART FAILURE,NCT02421341,Not Applicable,0.021280449627042727,0.9787195503729572
Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,_ONDANSETRON,ADVERSE REACTION TO OTHER DRUGS AND MEDICINES,NCT02436798,,0.47906562333048,0.5209343766695199
CNC1(c2ccccc2Cl)CCCCC1=O,_KETAMINE,FATIGUE,NCT04141696,Phase 1|Phase 2,0.17052022901779426,0.8294797709822059
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,_BUPIVACAINE,DIABETIC FOOT,NCT03871049,Not Applicable,0.016032344208822363,0.9839676557911776
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,_BUPIVACAINE,INGUINAL HERNIA,NCT04272320,Not Applicable,0.016435633951725183,0.9835643660482748
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,_BUPIVACAINE,CESAREAN SECTION,NCT03498118,Not Applicable,0.0424669300583992,0.9575330699416008
CNCCC=C1c2ccccc2CCc2ccccc21,_NORTRIPTYLINE,FUNCTIONAL DYSPEPSIA,NCT03652571,Phase 3,0.19834263203916733,0.8016573679608325
CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C,_ROPIVACAINE,INGUINAL HERNIA,NCT04033055,Not Applicable,0.13300400751679814,0.866995992483202
C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,_TRIAMCINOLONE,ASTHMA IN CHILDREN,NCT04002362,Phase 2,0.19632846767969067,0.8036715323203092
C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,_TRIAMCINOLONE,PSORIASIS,NCT04117919,Phase 2,0.016491077866995062,0.983508922133005
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_TRIAMCINOLONE_ACETONIDE,ASTHMA IN CHILDREN,NCT04002362,Phase 2,0.2986881425617424,0.7013118574382574
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,_PIOGLITAZONE,MULTIPLE SCLEROSIS,NCT03109288,Phase 1|Phase 2,0.09896897502611177,0.901031024973888
O=S(=O)(O)CCS,_MESNA,SICKLE CELL DISEASE,NCT03263559,Phase 2,0.5518928260725495,0.4481071739274505
O=S(=O)(O)CCS,_MESNA,CROHN'S DISEASE,NCT00692939,Phase 1|Phase 2,0.5790834600085853,0.42091653999141454
Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314,_NALBUPHINE,POSTOPERATIVE COMPLICATIONS,NCT03470077,Phase 2,0.09828566533575794,0.901714334664242
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_NALOXONE,PAIN,NCT04034004,Early Phase 1,0.1449935437882691,0.8550064562117309
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_NALOXONE,EPILEPSY,NCT02332447,Phase 3,0.10482012127296353,0.8951798787270363
CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,_IOHEXOL,ACUTE KIDNEY INJURY,NCT02772276,Phase 2,0.1941930666911168,0.8058069333088834
CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1,_TENOFOVIR_ALAFENAMIDE,HIV-1 INFECTION,NCT04301661,,0.16315220132491362,0.8368477986750864
COc1cc(CC(C)N)c(OC)cc1C,_DOM,CHRONIC HEPATITIS B,NCT02287857,Not Applicable,0.1593244348208922,0.8406755651791077
COc1cc(CC(C)N)c(OC)cc1C,_DOM,STROKE,NCT03828851,Not Applicable,0.0689395178768677,0.9310604821231324
COc1cc(CC(C)N)c(OC)cc1C,_DOM,HEMOPHILIA A,NCT03818763,Phase 1,0.31131899277030484,0.6886810072296953
CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1,_SOFOSBUVIR,HEPATITIS B INFECTION,NCT03312023,Phase 2,0.020638572009299087,0.9793614279907008
CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1,_SOFOSBUVIR,LIVER TRANSPLANT|HEPATITIS C,NCT03819322,Phase 2,0.0091816690719592,0.9908183309280408
COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1nc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5[nH]c([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)ccc2-3)c[nH]1)C(C)C,_LEDIPASVIR,HEPATITIS B INFECTION,NCT03312023,Phase 2,0.0998690260214818,0.9001309739785179
CS(=O)(=O)O.Nc1ncnc2c1ncn2CCOC[P@@]1(=O)OCC[C@@H](c2cccc(Cl)c2)O1,_PRADEFOVIR_MESYLATE,CHRONIC HEPATITIS B,NCT04543565,Phase 3,0.4267006252423773,0.5732993747576227
Nc1ncnc2c1ncn2CCOC[P@@]1(=O)OCC[C@@H](c2cccc(Cl)c2)O1,_PRADEFOVIR,CHRONIC HEPATITIS B,NCT04543565,Phase 3,0.3939531903587197,0.6060468096412803
NC[C@H]1CC[C@H](C(=O)O)CC1,_TRANEXAMIC_ACID,COVID-19,NCT04338074,Phase 2,0.14706740441154284,0.852932595588457
CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,_MISOPROSTOL,CLOSTRIDIUM DIFFICILE,NCT03617172,Phase 2,0.25798434336796844,0.7420156566320314
C[C@@H]1O[C@@H]1P(=O)(O)O,_FOSFOMYCIN,GONORRHEA,NCT03294395,Phase 3,0.0358921690981384,0.9641078309018616
CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.O=S(=O)(O)O,_GENTAMICIN_SULFATE,GONORRHEA,NCT03294395,Phase 3,0.4219400281853407,0.5780599718146593
CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.O=S(=O)(O)O,_GENTAMICIN_SULFATE,ABDOMINAL ABSCESS,NCT03476941,Phase 2,0.3032960082851255,0.6967039917148743
NC(N)=Nc1nc(CSCCC(N)=NS(N)(=O)=O)cs1,_FAMOTIDINE,COVID-19,NCT04370262,Phase 3,0.09412688334440264,0.9058731166555972
[Cl-].[K+],_POTASSIUM_CHLORIDE,HEART FAILURE,NCT02840799,Phase 2,0.30043259849508597,0.6995674015049143
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,_TOPOTECAN,OVARIAN CANCER,NCT03763123,Phase 1,0.3912148378271499,0.6087851621728503
CCN(CC)C(=S)SSC(=S)N(CC)CC,_DISULFIRAM,METASTATIC BREAST CANCER,NCT04265274,Phase 2,0.4584857556086128,0.5415142443913872
Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,_MARAVIROC,COVID-19,NCT04441385,Phase 2,0.006055283587898593,0.9939447164121016
Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,_MARAVIROC,STROKE,NCT03172026,Phase 2|Phase 3,0.00756154645844876,0.9924384535415514
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,_ALBUTEROL,INSULIN RESISTANCE,NCT04558190,Not Applicable,0.02465094911917303,0.9753490508808268
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,_SALBUTAMOL,INSULIN RESISTANCE,NCT04558190,Not Applicable,0.02465094911917303,0.9753490508808268
C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,_APREPITANT,COVID-19,NCT04470622,Phase 2,0.6739320228435265,0.3260679771564734
COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C,_RABEPRAZOLE,INFECTIOUS DISEASES,NCT04489797,Phase 1,0.10683995777244594,0.8931600422275541
CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,_MEGESTROL_ACETATE,BREAST CANCER,NCT03306472,Phase 2,0.11009580989763244,0.8899041901023678
NCCCC[C@H](N)C(=O)O,_LYSINE,HEART FAILURE,NCT03446651,Early Phase 1,0.280815103591086,0.7191848964089143
CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,_DOBUTAMINE,MYOCARDIAL INFARCTION,NCT03289728,Not Applicable,0.13266801529568106,0.8673319847043193
CN1CCN2c3ncccc3Cc3ccccc3C2C1,_MIRTAZAPINE,BREAST CANCER,NCT02336750,Phase 3,0.105281669619105,0.894718330380895
COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N,_RIOCIGUAT,SICKLE CELL DISEASE,NCT02633397,Phase 2,0.14481503190226908,0.8551849680977308
CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],_METHYLENE_BLUE,ABSCESS,NCT02240498,Phase 1,0.12433021197371985,0.8756697880262801
NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,_FUROSEMIDE,SEPTIC SHOCK,NCT04156451,Not Applicable,0.1125853881718883,0.8874146118281118
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,_ESTROGEN,URINARY TRACT INFECTIONS,NCT04301934,Not Applicable,0.03772404007535585,0.9622759599246442
COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,_TIVOZANIB,HEPATOCELLULAR CARCINOMA,NCT03970616,Phase 1|Phase 2,0.6152561345413736,0.3847438654586264
Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,_ALPRAZOLAM,TYPE 1 DIABETES,NCT03635437,Phase 1|Phase 2,0.17870187913909594,0.8212981208609038
C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O,_MUPIROCIN,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.10614377727041,0.89385622272959
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,BREAST CANCER,NCT02395614,Not Applicable,0.02699673667917716,0.9730032633208228
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,INFECTION,NCT03844776,Not Applicable,0.021282813095914368,0.9787171869040856
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.09637260759122343,0.9036273924087764
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,DIABETIC FOOT ULCER,NCT03503370,Phase 2,0.0113417753843214,0.9886582246156784
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,_CHLORHEXIDINE_GLUCONATE,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.2583511961040978,0.7416488038959023
Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,_SULFAMETHOXAZOLE,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.2622763547390053,0.7377236452609948
Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1,_ZOLPIDEM,PROSTATIC NEOPLASMS,NCT03436745,Phase 1,0.246333662824441,0.7536663371755589
CC(C)(O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)O,_CEFTAZIDIME,BACTERIAL INFECTION,NCT03978091,Phase 1,0.16899044627839951,0.8310095537216003
[N-]=[N+]=O,_NITROUS_OXIDE,ABSCESS,NCT03127371,Not Applicable,0.2853013308895591,0.7146986691104408
COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,_PRAZOSIN,COVID-19,NCT04365257,Phase 2,0.11071410376629022,0.8892858962337096
C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)c(CCC(=O)OC)c4C)[C@@]1(C)C3=CC=C(C(=O)OC)[C@H]1C(=O)OC,_VERTEPORFIN,RECURRENT PROSTATE CANCER,NCT03067051,Phase 1,0.50950804293775,0.4904919570622499
CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,_GEMIFLOXACIN,SPONTANEOUS BACTERIAL PERITONITIS,NCT04168099,Phase 3,0.0522608080385832,0.9477391919614168
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,_RIFAXIMIN,SPONTANEOUS BACTERIAL PERITONITIS,NCT04159870,Phase 3,0.0365640610374845,0.9634359389625154
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,_RIFAXIMIN,MICROBIAL COLONIZATION,NCT03529825,Early Phase 1,0.10076185536620866,0.8992381446337913
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,_RIFAXIMIN,TYPE 2 DIABETES,NCT03758144,Not Applicable,0.04944259810766338,0.9505574018923368
NC(=O)NO,_HYDROXYUREA,SICKLE CELL DISEASE,NCT04362293,Phase 2,0.3981933401414016,0.6018066598585985
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,_URSODIOL,LIVER DISEASES,NCT02943707,Phase 2,0.1660871970869252,0.8339128029130749
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,_URSODEOXYCHOLIC_ACID,LIVER DISEASES,NCT02943707,Phase 2,0.1660871970869252,0.8339128029130749
OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O,_PENTOSTATIN,SICKLE CELL DISEASE,NCT03077542,Phase 1|Phase 2,0.6552222001172439,0.34477779988275586
COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,_ZAFIRLUKAST,OVARIAN CANCER,NCT04339140,Phase 2,0.5521283955756939,0.4478716044243061
FS(F)(F)(F)(F)F,_SULFUR_HEXAFLUORIDE,CIRRHOSIS,NCT03407001,Early Phase 1,0.7502808990672429,0.2497191009327571
O=[As]O[As]=O,_ARSENIC_TRIOXIDE,HIV/AIDS,NCT03980665,Phase 1,0.35824969717174426,0.6417503028282562
OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,_LACTULOSE,CROHN'S DISEASE,NCT03962998,Early Phase 1,0.4343324746613097,0.5656675253386904
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)SCF,_FLUTICASONE,PHARMACOKINETICS,NCT03739294,Phase 2,0.016767489052905208,0.9832325109470949
Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3,_BUTORPHANOL,COLONOSCOPY,NCT04477733,Not Applicable,0.10960487277972064,0.890395127220279
O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],_NITROGLYCERIN,CARDIOVASCULAR DISEASE,NCT02115724,Not Applicable,0.4227526100354928,0.5772473899645073
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,_BARICITINIB,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03843125,Phase 3,0.2240325335700776,0.7759674664299222
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,_BARICITINIB,COVID-19,NCT04321993,Phase 2,0.1584536086040861,0.8415463913959138
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,_BARICITINIB,COVID-19 PNEUMONIA,NCT04346147,Phase 2,0.1421075902642161,0.8578924097357838
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,_BARICITINIB,ATOPIC DERMATITIS,NCT03952559,Phase 3,0.2042185235994781,0.7957814764005218
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,_TESTOSTERONE,PROSTATE CANCER,NCT03716739,Phase 2,0.19951027642628666,0.8004897235737132
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,_TESTOSTERONE,LIVER CIRRHOSIS,NCT03995251,Not Applicable,0.06601698042397812,0.9339830195760218
CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,_KETOCONAZOLE,PROSTATE CANCER,NCT00859781,Phase 2,0.19049057280630294,0.8095094271936969
CCCCCCOC(=O)/N=C(/N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1,_DABIGATRAN_ETEXILATE,ACUTE PANCREATITIS,NCT03807856,Phase 1,0.12185121847319245,0.8781487815268073
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[K+].[K+].[K+],_POTASSIUM_CITRATE,KIDNEY STONES,NCT03281928,Not Applicable,0.13225399550267875,0.8677460044973213
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,_HYDROCORTISONE_ACETATE,DEPRESSION,NCT02837432,Early Phase 1,0.2305465110133243,0.7694534889866756
O=[N+]([O-])[O-],_NITRATE,HEART FAILURE,NCT02840799,Phase 2,0.28379226747100217,0.7162077325289979
O=[N+]([O-])[O-],_NITRATE,HEART FAILURE|ARRHYTHMIA,NCT03658174,Not Applicable,0.1866644315073402,0.8133355684926598
Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,_MELOXICAM,ANKYLOSING SPONDYLITIS,NCT04480359,Phase 2|Phase 3,0.06739053751188,0.93260946248812
CC(=O)C(=O)O,_PYRUVATE,PROSTATE CANCER,NCT02913131,Phase 1|Phase 2,0.4529806325144088,0.5470193674855911
CC(=O)C(=O)O,_PYRUVATE,BREAST CANCER,NCT03121989,Phase 1,0.2795559336077065,0.7204440663922936
CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,_KETOTIFEN,FUNCTIONAL DYSPEPSIA,NCT02484248,Phase 3,0.13136682445990264,0.8686331755400972
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,_NORFLOXACIN,SPONTANEOUS BACTERIAL PERITONITIS,NCT04161768,Phase 3,0.01846083322792199,0.981539166772078
CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O,_ILOPROST,SEPTIC SHOCK,NCT04123444,Phase 2|Phase 3,0.11488422266866245,0.8851157773313374
CN(C)CCC=C1c2ccccc2COc2ccccc21,_DOXEPIN,BREAST CANCER,NCT02447211,Phase 2,0.20806552155273547,0.7919344784472644
Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1,_TOMIVOSERTIB,BREAST CANCER,NCT04261218,Phase 1,0.5470614473008312,0.4529385526991688
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C,_SEMAGLUTIDE,TYPE 1 DIABETES,NCT03899402,Phase 2|Phase 3,0.14391700481814804,0.8560829951818519
CCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N)c(=O)n1,_SAPACITABINE,BREAST CANCER,NCT03641755,Phase 1|Phase 2,0.5999819020318498,0.4000180979681502
CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C,_CICLESONIDE,COVID-19,NCT04377711,Phase 3,0.02899546652224062,0.9710045334777592
OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,_SUCROSE,PAIN,NCT04313179,Not Applicable,0.29086038029455463,0.7091396197054454
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,PAIN,NCT04132609,Not Applicable,0.6046180166604519,0.3953819833395481
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,OBSTRUCTIVE SLEEP APNEA,NCT02666781,,0.4770536292782357,0.5229463707217643
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,NICOTINE DEPENDENCE,NCT03325777,Not Applicable,0.6608811894073625,0.3391188105926372
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,ANXIETY,NCT04245501,Not Applicable,0.6375971907554062,0.3624028092445936
CCCCC/C=C\C/C=C\CCCCCCCC(=O)O,_LINOLEIC_ACID,CYSTIC FIBROSIS,NCT04531410,Not Applicable,0.157280143895586,0.8427198561044142
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O[C@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(NCc3ccc(-c4ccc(Cl)cc4)cc3)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,_ORITAVANCIN,GRAM POSITIVE BACTERIAL INFECTIONS,NCT02134301,Phase 1,0.04364200330967697,0.9563579966903232
CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1,_PERMETHRIN,MALARIA,NCT04102592,Not Applicable,0.08452508878370497,0.9154749112162952
CC[C@H](C)[C@H]1NC(=O)[C@@H](NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]2CCCN2C(=O)C(C)=O)[C@@H](C)OC(=O)[C@H](Cc2ccc(OC)cc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)C(=O)[C@H](C(C)C)OC(=O)C[C@@H]1O,_PLITIDEPSIN,COVID-19,NCT04382066,Phase 1,0.581404475818641,0.41859552418135904
N=C(N)NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)O,_ICATIBANT,COVID-19,NCT04488081,Phase 2,0.16812791906004962,0.8318720809399502
Cc1cn([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)c(=O)[nH]c1=O,_CLEVUDINE,COVID-19,NCT04347915,Phase 2,0.1088873131393236,0.8911126868606764
O=[O+][O-],_OZONE,ISCHEMIC HEART DISEASE,NCT03660657,Phase 2|Phase 3,0.11446774607746955,0.8855322539225304
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF,_FLUTICASONE_FUROATE,PHARMACOKINETICS,NCT03739294,Phase 2,0.03569108440909579,0.9643089155909044
Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,_CANAGLIFLOZIN,HEART FAILURE,NCT04252287,Phase 3,0.1990827433746726,0.8009172566253274
O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c(O)c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2,_BICTEGRAVIR,HIV/AIDS,NCT03789968,,0.15746617503556232,0.8425338249644377
OC[C@H](O)[C@@H](O)[C@H](O)CO,_XYLITOL,END STAGE RENAL DISEASE,NCT04001036,Phase 2,0.22923431971365496,0.7707656802863448
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)O,_ANGIOTENSIN_1-7,COVID-19,NCT04401423,Phase 2,0.32962668266849204,0.6703733173315081
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)O,_TXA127,COVID-19,NCT04401423,Phase 2,0.32962668266849204,0.6703733173315081
NC(=O)c1nc(F)cnc1O,_FAVIPIRAVIR,COVID,NCT04445467,Phase 2,0.2276579517801997,0.7723420482198001
NC(=O)c1nc(F)cnc1O,_FAVIPIRAVIR,CORONAVIRUS INFECTION,NCT04373733,Phase 3,0.2832488137589748,0.7167511862410252
O=[N+]([O-])c1nccn1CC(O)CN1CCCCC1,_PIMONIDAZOLE,PROSTATE CANCER,NCT02095249,Not Applicable,0.3039436564482576,0.6960563435517423
O=N[O-],_NITRITE,HEART FAILURE,NCT02713126,Phase 2,0.6357031759400145,0.3642968240599856
O=N[O-].[Na+],_SODIUM_NITRITE,HEART FAILURE,NCT02713126,Phase 2,0.7188090213000515,0.2811909786999482
COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c2n1,_PYRONARIDINE,COVID-19,NCT04475107,Phase 2,0.2053304739132537,0.7946695260867463
COC(=O)OCOc1c2n(ccc1=O)N([C@@H]1c3ccccc3SCc3c1ccc(F)c3F)[C@@H]1COCCN1C2=O,_BALOXAVIR_MARBOXIL,INFLUENZA,NCT03969212,Phase 3,0.18393879179679104,0.8160612082032089
O=C1c2c(O)c(=O)ccn2N([C@@H]2c3ccccc3SCc3c2ccc(F)c3F)[C@@H]2COCCN12,_BALOXAVIR,INFLUENZA,NCT03969212,Phase 3,0.3823989243619376,0.6176010756380624
Nc1ncc2ncn(CC3(OCP(=O)(O)O)CC3)c2n1,_BESIFOVIR,CHRONIC HEPATITIS B,NCT02792088,Phase 3,0.07727122587126041,0.9227287741287395
CC(C)(O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(CCNC(=O)c4ccc(O)c(O)c4Cl)CCCC3)CS[C@H]12)c1csc(N)n1)C(=O)O,_CEFIDEROCOL,BLOODSTREAM INFECTIONS,NCT03869437,Phase 2,0.2459858555748141,0.7540141444251858
N[C@@H](CSCC(=O)O)C(=O)O,_CARBOCYSTEINE,BRONCHIECTASIS,NCT04140214,Phase 3,0.32800481106224555,0.6719951889377543
Oc1cc(O)c2c(c1)OC(c1ccc(O)c(O)c1)C(O)C2,_CATECHIN,CIRRHOSIS,NCT03278925,Phase 1,0.5729956385477223,0.42700436145227777
OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O,_D-MANNOSE,URINARY TRACT INFECTIONS,NCT03395288,Phase 2|Phase 3,0.4015328067651506,0.5984671932348493
CCCCCC1=CC(=O)C=C(OC)C1=O,_PRIMIN,STROKE,NCT03517657,Not Applicable,0.19951201565792576,0.8004879843420742
NC(=O)OCC(COC(N)=O)c1ccccc1,_FELBAMATE,EPILEPSY,NCT03196466,,0.33075484217233936,0.6692451578276607
O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,_DANTROLENE,MULTIPLE SCLEROSIS,NCT03109288,Phase 1|Phase 2,0.4928417352763768,0.5071582647236234
Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,_ALPELISIB,BREAST CANCER,NCT03056755,Phase 2,0.3714245033100861,0.6285754966899141
COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1,_LETERMOVIR,CYTOMEGALOVIRUS INFECTION,NCT03728426,Phase 2,0.33332591652765786,0.6666740834723422
COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1,_LETERMOVIR,CYTOMEGALOVIRUS (CMV) INFECTION,NCT03940586,Phase 2,0.3749554479133737,0.6250445520866265
COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,_ERDAFITINIB,METASTATIC BREAST CANCER,NCT03238196,Phase 1,0.45546893238062397,0.5445310676193761
CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)CN5CCCC5)cc(F)c4C[C@H]3C[C@@H]12,_ERAVACYCLINE,BACTERIAL INFECTIONS,NCT03696550,Phase 1,0.23394586609520715,0.7660541339047927
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N,_OZANIMOD,CROHN'S DISEASE,NCT03467958,Phase 3,0.33474643250329805,0.6652535674967021
CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,_DAROLUTAMIDE,PROSTATE CANCER,NCT04136353,Phase 3,0.27870923717701,0.7212907628229901
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,CROHN'S DISEASE,NCT03345849,Phase 3,0.4273646942759424,0.5726353057240576
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,ATOPIC DERMATITIS,NCT03569293,Phase 3,0.43470439387827936,0.5652956061217206
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT04451772,Phase 2,0.4391962150400488,0.5608037849599513
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,SPONDYLOARTHRITIS,NCT04169373,Phase 3,0.4273646942759424,0.5726353057240576
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,ULCERATIVE COLITIS,NCT03006068,Phase 3,0.3999076091953635,0.6000923908046366
